Andrew J. Krentz

2012

This book aims to provide an update on drugs available for the treatment of type 2 diabetes and where they fit within current treatment algorithms. The limited efficacy and tolerability of older drugs has spurred the development of several new classes of oral and injectable glucose lowering agents with novel modes of action.